Investor.incyte.com

Investor Incyte. The Investor Relations website contains information about Incyte's business for stockholders, potential investors, and financial...

What’s new on Investor.incyte.com: Check updates and related news right now. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Investor.incyte.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Investor Incyte

Subscribe to related news

LSPPPO|HEALTHCARE NEWS|October 11, 2012
via elbiruniblogspotcom.blogspot

LSPPPO|HEALTHCARE NEWS|October 11, 2012 Healthcare News A Weekly Compilation of Clinical Laboratory and Related Information from The Division of Laboratory Science and Standards October 11, 2012 News Highlights Instructions for Clinical Teams Regarding...
Baricitinib Demonstrates Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis in Pivotal Ph...
via chemdiv

INDIANAPOLIS, IN, USA I October 14, 2015. Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announced positive topline results of RA-BEAM, the fourth successful Phase 3 study of baricitinib, an investigational medicine for...
Lilly and Incyte’s Oral RA Drug Demonstrates Superiority to Adalimumab in Phase III Trial
via spjnews

INDIANAPOLIS, Oct. 14, 2015 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announced positive topline results of RA-BEAM, the fourth successful Phase 3 study of baricitinib, an investigational medicine for...
APREMILAST …….FDA approves Celgene’s Otezla for psioratic arthritis
via newdrugapprovals.wordpress

APREMILAST PDE4 inhibitor N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide (+)-2-[l-(3-ethoxy-4-methoxyphenyl)-2- methanesulfonylethyl]-4-acetylaminoisoindolin-l,3-dione, (S)&mdash...
The Forgotten Organ – Your Microbiota
via wakingtimes

Dr. Mercola Waking Times Researchers are increasingly starting to recognize gut microbiota as one of your unappreciated “organs.”1 It may be even more apt to view your body as a “super organism” composed of symbiotic microorganisms...

Investor.incyte.com popular pages

Incyte - Investors - Investor FAQ

Where is Incyte located? When did Incyte go public? Incyte was established in 1991and went public in 1993. NASDAQ symbol: INCY. You can find the most recent stock price for INCY by clicking here....
Incyte - Investors - Press Release

Antje Hjerpe, Patient/Volunteer/ Advocate MPN-NET MPN Education Foundation. “But when we all join together – individuals, caregivers, advocates and health care professionals – our ...

Investors | Incyte

The Investor Relations website contains information about Incyte's business for stockholders, potential investors, and financial analysts.